
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
左巧云, 陶丽群, 罗秀, 等. 玉郎伞多糖抗鸭乙型肝炎病毒及保护肝细胞作用[J]. 中国实验方剂学杂志, 2013,19(22):222-226.
ZUO Qiao-yun, TAO Li-qun, LUO Xiu, et al. Polysaccharide Isolated from Yulangsan Inhibits Duck Hepatitis B Virus and Protects Hepatocytes[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(22): 222-226.
左巧云, 陶丽群, 罗秀, 等. 玉郎伞多糖抗鸭乙型肝炎病毒及保护肝细胞作用[J]. 中国实验方剂学杂志, 2013,19(22):222-226. DOI: 10.11653/syfj2013220222.
ZUO Qiao-yun, TAO Li-qun, LUO Xiu, et al. Polysaccharide Isolated from Yulangsan Inhibits Duck Hepatitis B Virus and Protects Hepatocytes[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(22): 222-226. DOI: 10.11653/syfj2013220222.
目的: 观察玉郎伞多糖(YLSP) 在鸭乙型肝炎病毒(DHBV)持续性感染模型中对鸭血清乙型肝炎病毒DNA的抑制作用及保护肝细胞的作用。 方法: 将DHBV-DNA强阳性麻鸭随机分为YLSP高、中、低剂量组(10
5
2.5 g·kg-1)、拉米夫定(3TC
0.05 g·kg-1) 组和模型组
以上各组每日上午灌胃给药 l 次
连续 14 d。于用药前(T0) 、用药7 d (T7)和14 d (T14)及停药后3 d (P3)取静脉血用实时荧光定量PCR检测DHBV-DNA含量
同时采用酶联免疫吸附(ELISA)法测定上清液鸭乙型肝炎病毒表面抗原(DHBsAg)和e抗原(DHBeAg)的滴度;在停药3 d后
取肝脏匀浆
检测肝匀浆液中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性以及丙二醛(MDA)、谷胱甘肽(GSH)的含量。 结果: 与模型组相比
YLSP高、中剂量治疗组给药7 d (T7)和14 d (T14)即能明显抑制DHBV-DNA复制及血清DHBsAg
DHBeAg的滴度显著降低(P<0.05或P<0.01)
停药后3 d (P3)
YLSP高剂量组仍能显示出持续有效
血清DHBV-DNA水平及血清DHBsAg
DHBeAg的滴度均无反跳现象 (P<0.05或P<0.01);在停药3d后
肝匀浆液中SOD
GSH-Px活性以及MDA
GSH的含量
YLSP高、中剂量组仍能显示出持续有效
没有出现反跳现象(P<0.05或P<0.01)。 结论: YLSP具有有效抑制DHBV-DNA和保护肝细胞的作用。
Objective: To study the inhibitory effect of Yulangsan polysaccharide (YLSP) on duck hepatitis B virus (DHBV) persistent infection in the model for the serum DHBV-DNA and the protecting effect on hepatocytes. Method: Ducklings were infected with DHBV and randomly divided the 3YLSPS dose groups(10
5
2.5 g·kg-1)
lamivudine (3TC
0.05 g·kg-1) and model groups respectively
continuous administration for 14 days. The serum content of DHBV-DNA was determined by real time fluorescent quantity polymerase chain reaction(FQ-PCR) method
DHBsAg and DHBeAg in serum were detected by ELISA before treatment and on the 7th
14th day after treatment and At 3 days after stopping treatment
took the liver homogenate and detected in liver and serum superoxide dismutase(SOD)
glutathione peroxidase(GSH-Px)activity and malondialdehyde(MDA)
L-glutathione (GSH) content. Result: Compared with modle group
the serum levels of DHBV-DNA
DHBsAg and DHBeAg decreased significantly 7 and 14 days after treatment with high-dose and middle-dose YLSP and at 3 days after stopping treatment the DHBV-DNA
DHBsAg and DHBeAg in serum in high-dose group were not rebounded
in liver and serum SOD
GSH-Px activity and MDA
GSH content
high-dose and middle-dose YLSP could still show a sustained and effective
no rebound phenomena (P < 0.05 or P < 0.01). Conclusion: YLSP can inhibit replication of DHBV and protect hepatocytes.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621